These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


72 related items for PubMed ID: 538697

  • 1. Identification of malignant transitional cells by their binding of fluorescein-labeled lectin.
    Daly JJ, Prout GR, Hagen K, Lin JC, Kamali HM, Plotkin GM, Wolf G.
    Surg Forum; 1979; 30():565-7. PubMed ID: 538697
    [No Abstract] [Full Text] [Related]

  • 2. Fluorescence cystoscopy.
    Vallancien G, Richard F, Haertig A, Mathieu F, Kuss R.
    Prog Clin Biol Res; 1984; 162A():327-30. PubMed ID: 6483915
    [No Abstract] [Full Text] [Related]

  • 3. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
    Moll R, Achtstätter T, Becht E, Balcarova-Ständer J, Ittensohn M, Franke WW.
    Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018
    [Abstract] [Full Text] [Related]

  • 4. Cellular heterogeneity in human transitional cell carcinoma: an analysis of optical properties and lectin binding.
    Ward GK, Stewart SS, Dotsikas G, Price GB, Mackillop WJ.
    Histochem J; 1992 Sep; 24(9):685-94. PubMed ID: 1429004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Proteome-based diagnostics and prognosis of bladder transitional cell carcinoma.
    Wu TF, Ku WL, Tsay YG.
    Expert Rev Proteomics; 2007 Oct; 4(5):639-47. PubMed ID: 17941819
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract.
    Chung SD.
    BJU Int; 2008 Aug; 102(4):518; author reply 518-9. PubMed ID: 18699961
    [No Abstract] [Full Text] [Related]

  • 11. [Electron microscopy in the diagnosis and prognosis of transitional-cell bladder tumors].
    Raĭkhlin NT, Romanenko AM, Klimenko IA, Shipilov VI, Iurakh GIu.
    Arkh Patol; 1986 Aug; 48(4):31-8. PubMed ID: 3718265
    [Abstract] [Full Text] [Related]

  • 12. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M, Fahmy M, Brainard JA, Pettay JD, Biscotti CV, Liou LS, Procop GW, Jones JS, Ulchaker J, Zippe CD, Tubbs RR.
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Usefulness of urinary nuclear matrix protein 22 (NMP22) as a marker for transitional cell carcinoma of the bladder.
    Menendez V, Filella X, Alcover JA, Molina R, Mallafre JM, Ballesta AM, Talbot-Wright R.
    Anticancer Res; 2000 Jun; 20(2B):1169-72. PubMed ID: 10810416
    [Abstract] [Full Text] [Related]

  • 15. Low grade transitional cell carcinoma and instrument artifact. A challenge in urinary cytology.
    Kannan V, Bose S.
    Acta Cytol; 1993 Jun; 37(6):899-902. PubMed ID: 8249510
    [Abstract] [Full Text] [Related]

  • 16. Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.
    Svatek RS, Herman MP, Lotan Y, Casella R, Hsieh JT, Sagalowsky AI, Shariat SF.
    Cancer; 2006 Apr 15; 106(8):1701-7. PubMed ID: 16541433
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Photodynamic effect and fluorescence in the diagnosis and therapy of the cancer of the bladder. (second part).
    Fedi B.
    Boll Soc Ital Biol Sper; 1977 Jul 30; 53(14):1145-9. PubMed ID: 75015
    [No Abstract] [Full Text] [Related]

  • 20. [Expression of bcl-2 and p16 in transitional cell carcinoma of urinary bladder].
    Leng J, Zhang Y, Yao X, Wen K.
    Zhonghua Wai Ke Za Zhi; 2000 Jan 30; 38(1):40-3. PubMed ID: 11831985
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.